Literature DB >> 29122022

Prognostic value of lymph node ratio in metastatic papillary thyroid carcinoma.

J Mansour1, D Sagiv1, E Alon1, Y Talmi1.   

Abstract

OBJECTIVE: Cervical metastases in papillary thyroid carcinoma are associated with increased recurrence. However, their effect on survival remains controversial. This study evaluated literature on the prognostic value of lymph node ratio for loco-regional recurrence and survival in metastatic papillary thyroid carcinoma.
METHODS: The PubMed database was systematically searched using the terms 'papillary thyroid carcinoma' and 'lymph node ratio'. Articles addressing the association between lymph node ratio and loco-regional recurrence or survival were identified.
RESULTS: Nine retrospective studies were included, comprising 12 400 post-thyroidectomy and neck dissection papillary thyroid carcinoma patients (median age, 48.6 years; 76 per cent females). Lymph node ratio was associated with worse recurrence-free survival in 60 and 75 per cent of studies investigating the effect of central compartment metastases and both central and lateral compartment metastases on recurrence-free survival, respectively. One large population-based study showed an association between lymph node ratio and disease-specific mortality in N1 nodal disease, but failed to maintain the same association when N1b patients were excluded.
CONCLUSION: Regional lymph node ratio is an independent predictor for loco-regional recurrence in pathologically staged N1 patients with papillary thyroid carcinoma. Patients with a high lymph node ratio should be closely followed up.

Entities:  

Keywords:  Carcinoma; Lymph Nodes; Neck Dissection; Neoplasm Metastasis; Papillary; Thyroid Cancer

Mesh:

Year:  2017        PMID: 29122022     DOI: 10.1017/S0022215117002250

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  15 in total

1.  The role of lymph node status in cancer-specific survival and decision-making of postoperative radiotherapy in poorly differentiated thyroid cancer: a population-based study.

Authors:  Maojie Zhang; Siyi Lei; Yuanyi Chen; Yuzhou Wu; Hui Ye
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma?

Authors:  Wenlong Wang; Ying Ding; Wei Jiang; Xinying Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

3.  Risk Factors That Influence Surgical Decision-Making for Patients with Low-Risk Differentiated Thyroid Cancer with Tumor Diameters of 1-4 cm.

Authors:  Xiangming Wang; Chao Zhang; Wenbin Yu; Akanksha Srivastava; Chuan Liu; Dongmin Wei; Yuncheng Li; Jianming Yang
Journal:  Cancer Manag Res       Date:  2020-12-02       Impact factor: 3.989

4.  Dual-energy computed tomography could reliably differentiate metastatic from non-metastatic lymph nodes of less than 0.5 cm in patients with papillary thyroid carcinoma.

Authors:  Ying Zou; Meizhu Zheng; Ziyu Qi; Yu Guo; Xiaodong Ji; Lixiang Huang; Yan Gong; Xiudi Lu; Guolin Ma; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-04

5.  Lymph node density in papillary thyroid carcinoma is a prognostic factor after adjusting for pathological stage.

Authors:  Hidenori Suzuki; Yusuke Koide; Nobuhiro Hanai; Daisuke Nishikawa; Shintaro Beppu; Shinji Mikami; Yasuhisa Hasegawa
Journal:  Oncotarget       Date:  2018-06-01

6.  Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.

Authors:  WenQian Zhang; Wei Sun; Yuan Qin; CangHao Wu; Liang He; Ting Zhang; Liang Shao; Hao Zhang; Ping Zhang
Journal:  J Cell Mol Med       Date:  2019-06-18       Impact factor: 5.310

7.  Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

8.  Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion, lower pathological tumor stages, and prolonged disease-free survival in papillary thyroid carcinoma patients.

Authors:  Huajie Ding; Xiaojie Wang; Huiling Liu; Lei Na
Journal:  J Clin Lab Anal       Date:  2021-05-09       Impact factor: 2.352

Review 9.  Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma.

Authors:  Yang Yang; Qin Chen; Wen-Ying Yu; Huan-Huan Zhang; Yu-Sen Zhong; Song-Zhao Zhang; Jia-Feng Wang; Chen-Huan Yu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

10.  MicroRNA-643 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma by down-regulating the cytochrome P450 family member 11B1.

Authors:  Hongqing Yin; Jun Shao
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.